Fig. 4

Flow cytometric analysis of the relative expression level of CD46 and CD55 proteins in AML and ALL patients. Flow cytometric analysis performed to measure the expression level of CD46 and CD55 in AML and ALL patients showed a significant reduction in CD46 expression in both types of acute leukemia patients. However, for CD55 a significant reduction was observed in AML patients only, while there was no significant difference observed in case of ALL patients. The expression level was calculated with reference to healthy controls. Data are represented as mean values ± SD for each sample done in duplicates, p < 0.05 (*).